Flash Therapeutics
French tech company | Builders Republic
About
CDMO specialized in lentiviral vector production for pharma and biotech clients developing gene and cell therapies — from process development and upstream/downstream manufacturing to quality control and regulatory-ready batches, GMP-compliant.
Key facts
- Status
- Morte
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Venture Round
- Founded
- 2005
- City
- TOULOUSE
- Region
- Occitanie
- Tracked rounds
- 1
- Amount raised
- 15 M€ raised since 2020
Funding rounds
- Venture Round — 2021
Investors
- Angel Investors Consortium
- Auriga Cyber Ventures
- Elaia Partners
- FaDièse
- FJ Investissements
- Galia Gestion
- Horizon 2020
- JMCR Family Office
- Nubbo
- Techlife Capital
- Viva Biotech
Notes
CDMO de vecteurs lentiviraux (Toulouse), rebaptisée Flash BioSolutions, placée en redressement judiciaire en novembre 2024 puis en liquidation judiciaire fin janvier 2025 (tribunal de commerce de Toulouse).